A short-term antihypertensive treatment-induced fall in glomerular filtration rate predicts long-term stability of renal function

Kidney International

Volumn 51, Issue 3, 1997, Pages 793-797

  Apperloo, Alfred J ^a   De Zeeuw, Dick ^a   De Jong, Paul E ^a,b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Division of Nephrology   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; ENALAPRIL;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; MALE; PRIORITY JOURNAL;

EID: 0030887031     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.111     Document Type: Article

References (16)

1. MOYER JH, HEIDER C, PEVEY K, FORD RV: The effect of treatment on the vascular deterioration associated with hypertension, with particular emphasis on renal function. Am J Med 24:177-192, 1958
2. REUBI FC: Role of physical factors in the acute changes in renal function elicited by antihypertensive drugs. Eur J Clin Pharmacol 13:185-193, 1978
3. MANN JF, REISCH C, RITZ E: Use of angiotensin-converting enzyme inhibitors for the preservation of kidney function. A retrospective study. Nephron 55:38-42, 1990
4. KLAHR S, LEVEY AS, BECK G, CAGGIULA AW, HUNSICKER L, KUSEK JW, STRIKER G: The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. N Engl J Med 330:877-884, 1994
5. HANSEN HP, ROSSING P, TARNOW L, NIELSEN FS, JENSEN B, PARVING HH: Increased glomerular filtration rate after withdrawal of long-term antihypertensive treatment in diabetic nephropathy. Kidney Int 47: 1726-1731, 1995
6. ANDERSON S, MEYER TW, RENNKE HG, BRENNER BM: Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 76:612-619, 1985
7. DONKER AJM, VAN DER HEM GK, SLUITER WJ, BEEKHUIS H: A radioisotope method for simultaneous determination of the glomerular filtration rate and the effective renal plasma flow. Neth J Med 20:97-103, 1977
8. BRAZY PC, STEAD WW, FITZWILLIAM JF: Progression of renal insufficiency: Role of blood pressure. Kidney Int 35:670-674, 1989
9. MASCHIO G, OLDRIZZI L, RUGIU C, VALVO E, LUPO A, LOSCHIAVO C, TESSITORE N, FABRIS A, GAMMARO L, PANZETTA G: Factors affecting progression of renal failure in patients on long-term dietary protein restriction. Kidney Int 32(Suppl 22):S49-S52, 1987
10. ROSMAN JB, LANGER K, BRANDL M, PIERS-BECHT TPM, VAN DER HEM GK, TER WEE PM, DONKER AJM: Protein-restricted diets in chronic renal failure: A four year follow-up shows limited indications. Kidney Int 36(Suppl 27):S96-S102, 1989
11. HANNEDOUCHE T, ALBOUZE G, CHAUVEAU P, LACOUR B, JUNGERS P: Effects of blood pressure and antihypertensive treatment on progression of advanced chronic renal failure. Am J Kidney Dis 21:131-137, 1993
12. ANDERSON S, RENNKE HG, BRENNER BM: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 77:1993-2000, 1986
13. REMUZZI A, PUNTORIERI S, BATTAGLIA C, BERTANI T, REMUZZI G: Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. J Clin Invest 85:541-549, 1990
14. PELAYO JC, QUAN AH, SHANLEY PF: Angiotensin II control of the renal microcirculation in rats with reduced renal mass. Am J Physiol 258:F414-F422, 1990
15. REKOLA S, BERGSTRAND A, BUCHT H: Deterioration rate in hypertensive IgA nephropathy: Comparison of a converting enzyme inhibitor and beta-blocking agents. Nephron 59:57-60, 1991
16. HANNEDOUCHE T, LANDAIS P, GOLDFARB B, ESPER NE, FOURNIER A, GODIN M, DURAND D, CHANARD J, MIGNON F, SUC J-M, GRÜNFELD J-P: Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure. Br Med J 309:833-837, 1994